[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613970":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":40,"centralContacts":45,"locations":31,"responsibleParty":51,"collaborators":31,"id":54,"slug":31,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":31,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":76,"overallStatus":81,"whyStopped":31,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":31},{"fullName":5,"class":6},"China National Center for Cardiovascular Diseases","OTHER_GOV",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"\"Smart family doctor\" assisted management","EXPERIMENTAL","\"Smart family doctor\", an AI-assisted applications with personalized interactions in 24 hours and 7 days a week.",[13],"Behavioral: Smart family doctor",{"label":15,"type":10,"description":16,"interventionNames":17},"Health managers","3-hour health management guidance from a health manager once a week.",[18],"Behavioral: Health manager",{"label":20,"type":21,"description":22,"interventionNames":23},"Usual care","PLACEBO_COMPARATOR","Usual post-surgery management",[24],"Behavioral: Usual Care",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"BEHAVIORAL","Smart family doctor","Participants will be provided \"Smart family doctor\", which is an AI-assisted applications with personalized interactions. The content includes, but is not limited to: (1) General educational content, covering basic health knowledge on diseases, risk factors, and treatment methods; (2) Targeted health information, such as more specific guidance on blood pressure and blood sugar control, medication adherence, exercise, and smoking cessation; (3) Personalized disease management guidance, providing tailored reminders for patients regarding medication, diet, exercise, and medical visits. Patients can also directly report their latest self-measured blood pressure, blood lipid, blood sugar levels, and medication adherence to receive treatment and medication guidance from the 'Smart family doctor'.",[9],null,{"type":27,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"Health manager","Participants will received 3-hour health management guidance from a health manager once a week, including guidance on healthy lifestyle, medication treatment, and rehabilitation advice.",[15],{"type":27,"name":37,"description":38,"armGroupLabels":39,"otherNames":31},"Usual Care","Participants will receive usual secondary prevention management.",[20],[41],{"name":42,"affiliation":43,"role":44},"Xin Yuan, PhD","Chinese Academy of Medical Sciences, Fuwai Hospital","PRINCIPAL_INVESTIGATOR",[46],{"name":47,"role":48,"phone":49,"phoneExt":31,"email":50},"Lihua Zhang, PhD","CONTACT","8601060866780","zhanglihua@fuwai.com",{"type":44,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Xin Yuan","Professor","100613970",false,"NCT07273513","\"Smart Family Doctor\" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients","SMART II","Inclusion Criteria:\n\n* Age 18-80 years.\n* Underwent CABG or PCI more than 3 months prior and have concurrent hypertension, diabetes, and dyslipidemia.\n* At least one of the following criteria is meet:\n* Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg\n* HbA1c no less than 7%\n* LDL-C no less than 1.4 mmol\u002FL\n* Signed informed consent.\n\nExclusion Criteria:\n\n* History of heart failure or severe arrhythmias.\n* Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.\n* Pregnancy, lactation, or plans for pregnancy within the next year.\n* Cognitive, communication impairments, or limitations in daily activities.\n* Unable to use smartphone.","ALL","18 Years","80 Years",{"count":64,"type":65},951,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study aims to evaluate the effect of an AI-assisted \"Smart family doctor\" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.",[71,72,73,74,75],"Hypertension","Diabete Mellitus","Hyperlipidemia","Post PCI","Post CABG",[77,78,79,80,28],"smartphone","AI-assisted","Revascularization management","metabolic management","NOT_YET_RECRUITING","2025-12-10",{"date":84,"type":85},"2025-12-18","ACTUAL",{"date":87,"type":65},"2026-01-15",{"date":89,"type":65},"2027-01-15",{"name":5,"class":6}]